Drugs / FOV1101-00
FOV1101-00
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00833495 | Jan → Mar 2009 | conjunctivitis | Fovea Pharmaceuticals SA | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FOV1101-00 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00833495 ↗ |
| Known as | CsA | “This investigational drug is a low dose cyclosporine (also known as cyclosporine A; CsA) formulation for topical ocular administration.” NCT00833495 ↗ |
| Known as | cyclosporine | “This investigational drug is a low dose cyclosporine (also known as cyclosporine A; CsA) formulation for topical ocular administration.” NCT00833495 ↗ |
| Known as | cyclosporine A | “This investigational drug is a low dose cyclosporine (also known as cyclosporine A; CsA) formulation for topical ocular administration.” NCT00833495 ↗ |
| Route | Topical | “for topical ocular administration” NCT00833495 ↗ |